NSIAD Tablet in pharma franchise in Gujarat

NSIAD Tablet in PCD pharma franchise in Shimla

NSIAD Tablet in top pharma company in Bangalore

NSIAD Tablet in pcd pharma supplier in Delhi

NSIAD Tablet in phama franchise company in India
NSIAD Tablet in phama distributor in Mumbai

Home/Products /nimesulide-100mg-paracetamol-325mg-serratiopeptidase-15mg-tablet

Nimoplit SP Tablet

Composition : Nimesulide (100mg) + Paracetamol (325mg) + Serratiopeptidase (15mg)

Dosage Form : Tablet

Packaging Type : Alu Alu

Packaging : 10*10

Price : ₹90/-

Nimoplit SP Tablet is a powerful combination medication designed to provide effective relief from pain, inflammation, and swelling. This tablet combines three potent ingredients to manage musculoskeletal conditions, post-operative inflammation, and other painful conditions.

  • Nimesulide, a non-steroidal anti-inflammatory drug (NSAID), effectively reduces pain and inflammation by inhibiting the production of prostaglandins, which are responsible for causing swelling, pain, and fever.
  • Paracetamol enhances the analgesic and antipyretic effects of the formulation, offering relief from fever and mild to moderate pain.
  • Serratiopeptidase, a proteolytic enzyme, helps reduce inflammation and swelling by breaking down proteins at the site of injury, improving recovery and alleviating discomfort.

This triple-action formula is highly effective in conditions such as arthritis, spondylitis, post-surgical pain, dental pain, and soft tissue injuries. Nimoplit SP Tablet provides comprehensive relief, addressing not just pain but also inflammation and swelling for faster healing and improved mobility.

Read More

About the Product

Nimoplit SP Tablet is a powerful combination medication designed to provide effective relief from pain, inflammation, and swelling. This tablet combines three potent ingredients to manage musculoskeletal conditions, post-operative inflammation, and other painful conditions.

  • Nimesulide, a non-steroidal anti-inflammatory drug (NSAID), effectively reduces pain and inflammation by inhibiting the production of prostaglandins, which are responsible for causing swelling, pain, and fever.
  • Paracetamol enhances the analgesic and antipyretic effects of the formulation, offering relief from fever and mild to moderate pain.
  • Serratiopeptidase, a proteolytic enzyme, helps reduce inflammation and swelling by breaking down proteins at the site of injury, improving recovery and alleviating discomfort.

This triple-action formula is highly effective in conditions such as arthritis, spondylitis, post-surgical pain, dental pain, and soft tissue injuries. Nimoplit SP Tablet provides comprehensive relief, addressing not just pain but also inflammation and swelling for faster healing and improved mobility.

Common side effects include nausea, stomach discomfort, dizziness, or diarrhea. Rare side effects may include allergic reactions or gastrointestinal bleeding.

Nimoplit SP Tablet is indicated for the management of pain, inflammation, and swelling associated with musculoskeletal disorders, post-surgical recovery, and injuries.

This medication should only be taken under medical supervision. Avoid use in individuals with severe liver or kidney impairment, a history of gastrointestinal ulcers, or hypersensitivity to any of the components.

Store in a cool, dry place below 30°C, away from direct sunlight and moisture. Keep out of reach of children.

Get in Touch

Regulatory Compliance & Professional Verification

This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.

  • No Consumer Sale: We do not entertain retail inquiries or direct sales to patients.
  • Information Accuracy: While we strive for accuracy, product availability, packaging, and regulatory status may change based on CDSCO guidelines and state-specific drug laws.
  • Medical Advice: Patients are strictly advised not to self-medicate or use this information for treatment. Always consult a qualified medical practitioner.
  • Licensing: All business associations are subject to the submission of valid GST and Drug License (DL) documentation.

Strategic Advisory

Ms. Shiwani Dhiman

VP-Strategic Outreach & Engagement

Ms. Shiwani specializes in market outreach and strategic partnership orchestration for entrepreneurs building scalable PCD Pharma Franchise models.

View Professional Profile

Start Your Journey

Partner With Cafoli

Ready to Dominate your territory with a Monopoly-Based PCD Franchise? Join our rapidly growing network of successful franchise partners and turn your ambitions into reality. Limited Territories Available — Don’t Miss Out!

Quick Navigation